Medicines and Healthcare products Regulatory Agency (MHRA) takes action to protect public health
The Medicines and Healthcare products Regulatory Agency (MHRA) has announced the reclassification of codeine linctus, an oral solution used to treat dry cough in adults, to a prescription-only medicine. This decision comes in response to mounting concerns over the risk of abuse, dependency, and overdose associated with the misuse of this opioid medication.
Stay connected to UKNIP via Google News
ENJOYED THIS STORY? Choose UKNIP as a 'Preferred Source' on Google News for quick access to the news you value.
